University of Texas Health Science Center

Site:	University of Texas Health Science Center
Address:
City:	San Antonio
State:	TX
Zip:	78229
Country:	USA

Phase [desc]	Trial	Trial Status	Site Status	Drug	NCT#
3	Imatinib Mesylate With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor	Terminated	Closed	Imatinib + Bevacizumab	NCT00324987